CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,312,833 | -20.0% | 544,196 | 0.0% | 7.30% | -17.6% |
| Q1 2023 | $2,889,681 | -15.4% | 544,196 | 0.0% | 8.86% | -21.4% |
| Q4 2022 | $3,417,551 | -40.5% | 544,196 | 0.0% | 11.27% | -42.2% |
| Q3 2022 | $5,741,000 | +73.5% | 544,196 | -10.7% | 19.52% | +78.5% |
| Q2 2022 | $3,308,000 | -46.6% | 609,196 | -9.6% | 10.93% | +52.5% |
| Q1 2022 | $6,189,000 | -39.2% | 674,196 | 0.0% | 7.17% | +12.1% |
| Q4 2021 | $10,174,000 | -36.8% | 674,196 | 0.0% | 6.39% | -36.2% |
| Q3 2021 | $16,093,000 | – | 674,196 | – | 10.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |